These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8834889)

  • 1. The guanine nucleoside analog penciclovir is active against chronic duck hepatitis B virus infection in vivo.
    Lin E; Luscombe C; Wang YY; Shaw T; Locarnini S
    Antimicrob Agents Chemother; 1996 Feb; 40(2):413-18. PubMed ID: 8834889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nucleoside analogue therapy on duck hepatitis B viral replication in hepatocytes and bile duct epithelial cells in vivo.
    Nicoll A; Locarnini S; Chou ST; Smallwood R; Angus P
    J Gastroenterol Hepatol; 2000 Mar; 15(3):304-10. PubMed ID: 10764033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term therapy with the guanine nucleoside analog penciclovir controls chronic duck hepatitis B virus infection in vivo.
    Lin E; Luscombe C; Colledge D; Wang YY; Locarnini S
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2132-7. PubMed ID: 9687423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral activities of penciclovir and famciclovir on duck hepatitis B virus in vitro and in vivo.
    Offensperger WB; Offensperger S; Keppler-Hafkemeyer A; Hafkemeyer P; Blum HE
    Antivir Ther; 1996 Aug; 1(3):141-6. PubMed ID: 11322247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral famciclovir against duck hepatitis B virus replication in hepatic and nonhepatic tissues of ducklings infected in ovo.
    Tsiquaye KN; Slomka MJ; Maung M
    J Med Virol; 1994 Mar; 42(3):306-10. PubMed ID: 8006644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of duck hepatitis B virus replication by 9-(2-phosphonylmethoxyethyl)adenine, an acyclic phosphonate nucleoside analogue.
    Nicoll AJ; Colledge DL; Toole JJ; Angus PW; Smallwood RA; Locarnini SA
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3130-5. PubMed ID: 9835503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SATE pronucleotide approach applied to acyclovir: part II. Effects of bis(SATE)phosphotriester derivatives of acyclovir on duck hepatitis B virus replication in vitro and in vivo.
    Hantz O; Périgaud C; Borel C; Jamard C; Zoulim F; Trépo C; Imbach JL; Gosselin G
    Antiviral Res; 1999 Jan; 40(3):179-87. PubMed ID: 10027652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the antiviral effects of 2' carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virus.
    Mason WS; Cullen J; Saputelli J; Wu TT; Liu C; London WT; Lustbader E; Schaffer P; O'Connell AP; Fourel I
    Hepatology; 1994 Feb; 19(2):398-411. PubMed ID: 8294097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo.
    Zoulim F; Dannaoui E; Borel C; Hantz O; Lin TS; Liu SH; Trépo C; Cheng YC
    Antimicrob Agents Chemother; 1996 Feb; 40(2):448-53. PubMed ID: 8834896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in intrahepatic expression of duck hepatitis B viral markers with ganciclovir chemotherapy.
    Luscombe C; Pedersen J; Bowden S; Locarnini S
    Liver; 1994 Aug; 14(4):182-92. PubMed ID: 7968278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus.
    Shaw T; Amor P; Civitico G; Boyd M; Locarnini S
    Antimicrob Agents Chemother; 1994 Apr; 38(4):719-23. PubMed ID: 8031035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antihepadnaviral activities of combinations of penciclovir, lamivudine, and adefovir.
    Colledge D; Civitico G; Locarnini S; Shaw T
    Antimicrob Agents Chemother; 2000 Mar; 44(3):551-60. PubMed ID: 10681317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks.
    Fourel I; Cullen JM; Saputelli J; Aldrich CE; Schaffer P; Averett DR; Pugh J; Mason WS
    J Virol; 1994 Dec; 68(12):8321-30. PubMed ID: 7966625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term ganciclovir chemotherapy for congenital duck hepatitis B virus infection in vivo: effect on intrahepatic-viral DNA, RNA, and protein expression.
    Luscombe C; Pedersen J; Uren E; Locarnini S
    Hepatology; 1996 Oct; 24(4):766-73. PubMed ID: 8855174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversion of duck hepatitis B virus DNA replication in vivo following cessation of treatment with the nucleoside analogue ganciclovir.
    Dean J; Bowden S; Locarnini S
    Antiviral Res; 1995 May; 27(1-2):171-8. PubMed ID: 7486954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the antiviral effect of 2',3'-dideoxy-2', 3'-didehydro-beta-L-5-fluorocytidine in the duck hepatitis B virus infection model.
    Le Guerhier F; Pichoud C; Guerret S; Chevallier M; Jamard C; Hantz O; Li XY; Chen SH; King I; Trépo C; Cheng YC; Zoulim F
    Antimicrob Agents Chemother; 2000 Jan; 44(1):111-22. PubMed ID: 10602731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal models for the study of HBV infection and the evaluation of new anti-HBV strategies.
    Zoulim F; Berthillon P; Guerhier FL; Seigneres B; Germon S; Pichoud C; Cheng YC; Trepo C
    J Gastroenterol Hepatol; 2002 Dec; 17 Suppl():S460-3. PubMed ID: 12534778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of 2'-fluoro-5-methyl-beta-L-arabinofuranosyl-uracil on duck hepatitis B virus replication.
    Aguesse-Germon S; Liu SH; Chevallier M; Pichoud C; Jamard C; Borel C; Chu CK; Trépo C; Cheng YC; Zoulim F
    Antimicrob Agents Chemother; 1998 Feb; 42(2):369-76. PubMed ID: 9527788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease of wild-type and precore mutant duck hepatitis B virus replication during lamivudine treatment in white Pekin ducks infected with the viruses.
    Tomita T; Yokosuka O; Tagawa M; Saisho H; Tamura S; Fukuda I; Omata M
    J Hepatol; 2000 May; 32(5):850-8. PubMed ID: 10845674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic inhibition of hepadnaviral replication by lamivudine in combination with penciclovir in vitro.
    Colledge D; Locarnini S; Shaw T
    Hepatology; 1997 Jul; 26(1):216-25. PubMed ID: 9214473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.